다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
European journal of integrative medicine, v.7 no.1, 2015년, pp.55 - 66
He, T.T. , Ung, C.O.L. , Hu, H. , Wang, Y.T.
AI-Helper
Introduction: Herbal products are widely used worldwide. In the context of globalization, quality control of these products has become an increasingly important issue not only for the consumers but also for regulators and manufacturers. Laws, regulations and guidelines stipulating requirements of go...
British Medical Association 1993 Complementary medicine: new approaches to good practice
Zhang 2002
Organization 2007 WHO guidelines on good manufacturing practices (GMP) for herbal medicines
Br J Dermatol Ferguson 136 592 1997 10.1046/j.1365-2133.1997.d01-1241.x Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine
Eur J Gastroenterol Hepatol McRae 14 559 2002 10.1097/00042737-200205000-00015 Hepatitis associated with Chinese herbs
N Engl J Med Nortier 342 1686 2000 10.1056/NEJM200006083422301 Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)
Forsch Komplement/Res Complement Med Pach 9 352 2003 10.1159/000069235 Availability of research results on traditional Chinese pharmacotherapy
Braz J Med Biol Res Calixto 33 179 2000 10.1590/S0100-879X2000000200004 Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
Bol Latinoam Caribe Plant Med Aromat Mukherjee 6 129 2007 An overview on the development in regulation and control of medicinal and aromatic plants in the Indian system of medicine
Cohen 1998 Complementary & alternative medicine: legal boundaries and regulatory perspectives
J AOAC Int Ong 82 963 1999 10.1093/jaoac/82.4.963 Determination of arsenic in traditional Chinese medicine by microwave digestion with flow injection-inductively coupled plasma mass spectrometry (FI-ICP-MS)
Br J Clin Pharmacol Barnes 55 226 2003 10.1046/j.1365-2125.2003.01810.x Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality
Chin Pharm Aff Bo 1 25 2009 The progress of GMP management consciousness
TQM Mag Krasachol 10 40 1998 10.1108/09544789810197837 The progress of quality management in Thailand
Toxicology Briggs 181 565 2002 10.1016/S0300-483X(02)00483-3 The regulation of herbal medicines in Australia
Zhang 1998 Regulatory situation of herbal medicines. A worldwide review. WHO/TRM/98.1
Integr Med Liu 9 54 2010 Herbal medicine regulation in China, Germany, and the United States
TDV. New Chinese, EU and US GMPs comparative overview. Available at http://www.tdvct.com/Fitnews/COMPARATIVE%20OVERVIEW.pdf.
Chin Pharm Aff Zhang 24 3 302 2010 Compare research of PIC/S, PIC//S GMP and Chinese GMP
Chin Pharm Aff CFDA 22 843 2008 Contrast research report of domestic and foreign drug GMP
J Ethnopharmacol Fan 140 568 2012 10.1016/j.jep.2012.02.029 Future development of global regulations of Chinese herbal products
Evid Based Complement Altern Med Park 2012 429103 2012 10.1155/2012/429103 Traditional medicine in China, Korea, and Japan: a brief introduction and comparison
Altern Ther Health Med Tindle 11 1 42 2005 Trends in use of complementary and alternative medicine by US adults: 1997-2002
Health Policy Xu 90 133 2009 10.1016/j.healthpol.2008.09.003 Traditional Chinese medicine in the Chinese health care system
FDA 2012 FDA Foods Program, The Reportable Food Registry: A New Approach to Targeting Inspection Resources and Identifying Patterns of Adulteration. Second Annual Report: September 8, 2010-September 7, 2011
Am J Law Med McCann 31 215 2005 10.1177/009885880503100204 Dietary supplement labeling: cognitive biases, market manipulation & (and) consumer choice
FDA 2010 Guidance for Industry: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Small Entity Compliance Guide
FDA. Proposed Rule Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Human Food; 2011N-0921.
Amber Waves Hoffmann 9 24 2011 US food safety policy enters a new era
Chin Pharm Aff Liu 23 286 2009 Review and prospect of the good manufacturing practice in China
Cap Med Chen 1 9 2008 The history and development of the good manufacturing practice in China
Pharm Eng Design Liu 28 43 2007 Comparison and research of drug GMP in China and USA
WHO 2005 National policy on traditional medicine and regulation of herbal medicines: report of a WHO global survey
China Licens Pharmacist Xu 8 46 2011 Primary study on the implementation of quality risk management of GMP
European Commission 2008 The Rules Governing Medicinal Products in the European Union: EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use
European Commission 2014 Revision of European Commission Guidelines on Good Manufacturing Practice for Medicinal Products
HSA 2013 Pharmaceutical Inspection Convention/Co-operation Scheme (PIC/S) Guide to Good Manufacturing Practice (GMP) for Medicinal Products
Drug Saf Koh 23 351 2000 10.2165/00002018-200023050-00001 Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs
HSA 2012 Updates on PIC/S GMP Standard including Site Master File guidance
Complementary Healthcare Council 2013 Submission to the Therapeutic Goods Administration on the Proposal for automatic adoption of new versions of the PIC/S Guide to Good Manufacturing Practice for Medicinal Products
Mech Electr Inf Yu 2010 6 2010 Comparison and research of GMP in China and US
J Gen Intern Med Bent 23 854 2008 10.1007/s11606-008-0632-y Herbal medicine in the United States: review of efficacy, safety, and regulation
Herbal Gram Soller 93 42 2012 The regulated dietary supplement industry: myths of an unregulated industry dispelled
Health Policy Yee 71 133 2005 10.1016/j.healthpol.2003.09.013 Regulatory control of Chinese proprietary medicines in Singapore
World Health Forum Akerele 14 390 1993 Natures medicinal bounty: don’t throw it away
Bol Latinoam Caribe Plant Med Aromat Peschel 6 102 2007 The traditional herbal medicine directive within the European regulatory framework for herbal products
WHO vol. 2 2007
China Pharmacist Bai 6 679 2003 The current status and development of implementation of GMP in China
FDA 2010 New Dietary Ingredients in Dietary Supplements-Background for Industry, What Information Must the Notification Contain?
J Transnatl Law Policy Mason 20 103 2010 Dietary supplementary regulation: a comparative study
2005 HSA Annual report. Conquering New Challenges: Health Products Regulation Group
Compr Rev Food Sci Food Saf Wheatley 12 599 2013 10.1111/1541-4337.12033 Defining the public health threat of dietary supplement fraud
Sloan Manage Rev Antia 64 63 2004 Competing with gray markets
Am Health Drug Benefits Kuznar 2 67 2009 Prominent cardiologist hammers the FDA: insufficient funding compromises the science of drug approvals
Arch Intern Med Blendon 161 805 2001 10.1001/archinte.161.6.805 American's vies on the use and regulation of dietary supplements
Indian J Nat Prod Panchawat 19 11 2003 Standardization and evaluation of herbal drug formulation
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.